表紙
市場調查報告書

全球支氣管炎治療市場:產業分析,規模,佔有率,成長,趨勢,預測

Bronchitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

出版商 Transparency Market Research 商品編碼 823543
出版日期 內容資訊 英文 176 Pages
商品交期: 最快1-2個工作天內
價格
全球支氣管炎治療市場:產業分析,規模,佔有率,成長,趨勢,預測 Bronchitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
出版日期: 2019年03月19日內容資訊: 英文 176 Pages
簡介

本報告提供全球支氣管炎治療市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介等相關資訊。

第1章 序論

第2章 假設和調查方法

第3章 摘要整理

第4章 市場概要

  • 類型概要
  • 產業趨勢
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
    • 趨勢
  • 市場收益預測
  • 波特五力分析
  • 市場預測

第5章 市場預測

  • 開發平台分析
  • 市場趨勢
  • 流行病學

第6章 各類型市場分析與預測

  • 主要調查結果
  • 市場值佔有率與魅力度分析
  • 市場值預測
    • 急性支氣管炎
    • 慢性支氣管炎
  • 市場魅力度

第7章 各類藥物市場分析與預測

  • 主要調查結果
  • 市場值佔有率與魅力度分析
  • 市場值預測
    • 抗生素
    • 消炎藥
    • 支氣管擴張劑
    • 粘液溶解劑
  • 市場魅力度

第8章 各流通管道市場分析

  • 主要調查結果
  • 市場值佔有率與魅力度分析
  • 市場值預測
    • 院內藥局
    • 零售藥局
    • 線上藥局
  • 市場魅力度

第9章 各地區市場分析與預測

  • 市場方案
  • 市場值預測與魅力度分析
  • 市場值預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲

第10章 北美市場

第11章 歐洲市場

第12章 亞太地區市場

第13章 南美市場

第14章 中東·非洲市場

第15章 競爭環境

  • 市場佔有率分析
  • 競爭矩陣
  • 企業簡介
目錄

Title:
Bronchitis Treatment Market (Type - Chronic Bronchitis, Acute Bronchitis; Drug Class - Antibiotics, Anti-inflammatory Drugs, Bronchodilator, Mucolytics; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Global Bronchitis Treatment market: Overview:

This report analyzes the current and future scenario of the global bronchitis treatment market. Rise in geriatric population, high incidence of bronchitis, and increase in cigarette smoking patient pool are major drivers of the global market.

The global bronchitis treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to segments based on type, drug class, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global bronchitis treatment market.

Global Bronchitis Treatment Market: Key Segments:

The global bronchitis treatment market has been segmented based on type, drug class, distribution channel, and region. Furthermore, in terms of type, the market has been divided into chronic bronchitis and acute bronchitis. The chronic bronchitis segment is likely to account for a leading share of the global market during the forecast period owing to high morbidity and mortality rate. Based on drug class, the bronchitis treatment market has been classified into antibiotics, anti-inflammatory drugs, bronchodilators, and mucolytics. In terms of distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment held a significant share of the market in 2017 due to a rise in the sale of over-the-counter bronchitis therapeutics. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Bronchitis Treatment Market: Regional Outlook:

In terms of region, the global bronchitis treatment market has been segmented into five major regions and key countries/sub-regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report:

The report also profiles major players in the global bronchitis treatment market based on various attributes such as company overview, financial overview, type portfolio, business strategies, and recent developments. Key players in the global bronchitis treatment market are AstraZeneca, Novartis AG, GlaxoSmithKline plc, Dr. Reddy's Laboratories Ltd., Melinta Therapeutics, Sanofi Aventis, and Boehringer Ingelheim International GmbH.

The global bronchitis treatment market has been segmented as given below:

Global Bronchitis Treatment Market, by Type

  • Acute Bronchitis
  • Chronic Bronchitis

Global Bronchitis Treatment Market, by Drug Class

  • Antibiotics
  • Anti-inflammatory Drugs
  • Bronchodilators
  • Mucolytics

Global Bronchitis Treatment Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Bronchitis Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions and Acronyms Used
  • 2.2. Research Methodology

3. Executive Summary

  • 3.1. Global Bronchitis Treatment Market: Market Snapshot

4. Market Overview

  • 4.1. Global Bronchitis Treatment Market: Type Overview
  • 4.2. Global Bronchitis Treatment Market: Key Industry Developments
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Bronchitis Treatment Market Revenue Projections, 2016-2026
  • 4.5. Porter's Five Forces Analysis
  • 4.6. Global Bronchitis Treatment Market Outlook

5. Market Outlook

  • 5.1. Pipeline Analysis
  • 5.2. Key Market Trends
  • 5.3. Disease Epidemiology

6. Global Bronchitis Treatment Market Analysis, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
  • 6.3. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Type
  • 6.4. Global Bronchitis Treatment Market Value Forecast, by Type
    • 6.4.1. Acute Bronchitis
    • 6.4.2. Chronic Bronchitis
  • 6.5. Global Bronchitis Treatment Market Analysis, by Type

7. Global Bronchitis Treatment Market Analysis and Forecast, by Drug Class

  • 7.1. Key Findings
  • 7.2. Introduction
  • 7.3. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Drug Class
  • 7.4. Global Bronchitis Treatment Market Value Forecast, by Drug Class
    • 7.4.1. Antibiotics
    • 7.4.2. Anti-inflammatory Drugs
    • 7.4.3. Bronchodilators
    • 7.4.4. Mucolytics
  • 7.5. Global Bronchitis Treatment Market Analysis, by Drug Class

8. Global Bronchitis Treatment Market Analysis, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
  • 8.3. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 8.4. Global Bronchitis Treatment Market Value Forecast, by Distribution Channel
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Online Pharmacies
  • 8.5. Global Bronchitis Treatment Market Analysis, by Distribution Channel

9. Global Bronchitis Treatment Market Analysis, by Region

  • 9.1. Global Bronchitis Treatment Market Scenario, by Country
  • 9.2. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Region
  • 9.3. Global Bronchitis Treatment Market Value Forecast, by Region
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East & Africa

10. North America Bronchitis Treatment Market Analysis

  • 10.1. Key Findings
  • 10.2. North America Bronchitis Treatment Market Overview
  • 10.3. North America Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Country
  • 10.4. North America Bronchitis Treatment Market Forecast, by Country
    • 10.4.1. U.S.
    • 10.4.2. Canada
  • 10.5. North America Bronchitis Treatment Market Value Share Analysis, by Type
  • 10.6. North America Bronchitis Treatment Market Forecast, by Type
    • 10.6.1. Acute Bronchitis
    • 10.6.2. Chronic Bronchitis
  • 10.7. North America Bronchitis Treatment Market Value Share Analysis, by Drug Class
  • 10.8. North America Bronchitis Treatment Market Forecast, by Drug Class
    • 10.8.1. Antibiotics
    • 10.8.2. Anti-inflammatory Drugs
    • 10.8.3. Bronchodilators
    • 10.8.4. Mucolytics
  • 10.9. North America Bronchitis Treatment Market Value Share Analysis, by Distribution Channel
  • 10.10. North America Bronchitis Treatment Market Forecast, by Distribution Channel
    • 10.10.1. Hospital Pharmacies
    • 10.10.2. Retail Pharmacies
    • 10.10.3. Online Pharmacies
  • 10.11. North America Bronchitis Treatment Market Attractiveness Analysis

11. Europe Bronchitis Treatment Market Analysis

  • 11.1. Key Findings
  • 11.2. Europe Bronchitis Treatment Market Overview
  • 11.3. Europe Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 11.4. Europe Bronchitis Treatment Market Forecast, by Country/Sub-region
    • 11.4.1. Germany
    • 11.4.2. U.K.
    • 11.4.3. France
    • 11.4.4. Italy
    • 11.4.5. Spain
    • 11.4.6. Rest of Europe
  • 11.5. Europe Bronchitis Treatment Market Value Share Analysis, by Type
  • 11.6. Europe Bronchitis Treatment Market Forecast, by Type
    • 11.6.1. Acute Bronchitis
    • 11.6.2. Chronic Bronchitis
  • 11.7. Europe Bronchitis Treatment Market Value Share Analysis, by Drug Class
  • 11.8. Europe Bronchitis Treatment Market Forecast, by Drug Class
    • 11.8.1. Antibiotics
    • 11.8.2. Anti-inflammatory Drugs
    • 11.8.3. Bronchodilators
    • 11.8.4. Mucolytics
  • 11.9. Europe Bronchitis Treatment Market Value Share Analysis, by Distribution Channel
  • 11.10. Europe Bronchitis Treatment Market Forecast, by Distribution Channel
    • 11.10.1. Hospital Pharmacies
    • 11.10.2. Retail Pharmacies
    • 11.10.3. Online Pharmacies
  • 11.11. Europe Bronchitis Treatment Market Attractiveness Analysis

12. Asia Pacific Bronchitis Treatment Market Analysis

  • 12.1. Key Findings
  • 12.2. Asia Pacific Bronchitis Treatment Market Overview
  • 12.3. Asia Pacific Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 12.4. Asia Pacific Bronchitis Treatment Market Forecast, by Country/Sub-region
    • 12.4.1. China
    • 12.4.2. India
    • 12.4.3. Japan
    • 12.4.4. Australia & New Zealand
    • 12.4.5. Rest of Asia Pacific
  • 12.5. Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Type
  • 12.6. Asia Pacific Bronchitis Treatment Market Forecast, by Type
    • 12.6.1. Acute Bronchitis
    • 12.6.2. Chronic Bronchitis
  • 12.7. Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Drug Class
  • 12.8. Asia Pacific Bronchitis Treatment Market Forecast, by Drug Class
    • 12.8.1. Antibiotics
    • 12.8.2. Anti-inflammatory Drugs
    • 12.8.3. Bronchodilators
    • 12.8.4. Mucolytics
  • 12.9. Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Distribution Channel
  • 12.10. Asia Pacific Bronchitis Treatment Market Forecast, by Distribution Channel
    • 12.10.1. Hospital Pharmacies
    • 12.10.2. Retail Pharmacies
    • 12.10.3. Online Pharmacies
  • 12.11. Asia Pacific Bronchitis Treatment Market Attractiveness Analysis

13. Latin America Bronchitis Treatment Market Analysis

  • 13.1. Key Findings
  • 13.2. Latin America Bronchitis Treatment Market Overview
  • 13.3. Latin America Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 13.4. Latin America Bronchitis Treatment Market Forecast, by Country/Sub-region
    • 13.4.1. Brazil
    • 13.4.2. Mexico
    • 13.4.3. Rest of Latin America
  • 13.5. Latin America Bronchitis Treatment Market Value Share Analysis, by Type
  • 13.6. Latin America Bronchitis Treatment Market Forecast, by Type
    • 13.6.1. Acute Bronchitis
    • 13.6.2. Chronic Bronchitis
  • 13.7. Latin America Bronchitis Treatment Market Value Share Analysis, by Drug Class
  • 13.8. Latin America Bronchitis Treatment Market Forecast, by Drug Class
    • 13.8.1. Antibiotics
    • 13.8.2. Anti-inflammatory Drugs
    • 13.8.3. Bronchodilators
    • 13.8.4. Mucolytics
  • 13.9. Latin America Bronchitis Treatment Market Value Share Analysis, by Distribution Channel
  • 13.10. Latin America Bronchitis Treatment Market Forecast, by Distribution Channel
    • 13.10.1. Hospital Pharmacies
    • 13.10.2. Retail Pharmacies
    • 13.10.3. Online Pharmacies
  • 13.11. Latin America Bronchitis Treatment Market Attractiveness Analysis

14. Middle East & Africa Bronchitis Treatment Market Analysis

  • 14.1. Key Findings
  • 14.2. Middle East & Africa Bronchitis Treatment Market Overview
  • 14.3. Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Country/Sub-region
  • 14.4. Middle East & Africa Bronchitis Treatment Market Forecast, by Country/Sub-region
    • 14.4.1. GCC Countries
    • 14.4.2. South Africa
    • 14.4.3. Rest of Middle East and Africa
  • 14.5. Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Type
  • 14.6. Middle East & Africa Bronchitis Treatment Market Forecast, by Type
    • 14.6.1. Acute Bronchitis
    • 14.6.2. Chronic Bronchitis
  • 14.7. Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Drug Class
  • 14.8. Middle East & Africa Bronchitis Treatment Market Forecast, by Drug Class
    • 14.8.1. Antibiotics
    • 14.8.2. Anti-inflammatory Drugs
    • 14.8.3. Bronchodilators
    • 14.8.4. Mucolytics
  • 14.9. Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Distribution Channel
  • 14.10. Middle East & Africa Bronchitis Treatment Market Forecast, by Distribution Channel
    • 14.10.1. Hospital Pharmacies
    • 14.10.2. Retail Pharmacies
    • 14.10.3. Online Pharmacies
  • 14.11. Middle East & Africa Bronchitis Treatment Market Attractiveness Analysis

15. Competition Landscape

  • 15.1. Bronchitis Treatment Market Share Analysis, by Company, 2017
  • 15.2. Competition Matrix
  • 15.3. Company Profiles
    • 15.3.1. AstraZeneca
      • 15.3.1.1. Company Details
      • 15.3.1.2. Business Overview
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. Strategic Overview
      • 15.3.1.5. SWOT Analysis
    • 15.3.2. Boehringer Ingelheim International GmbH
      • 15.3.2.1. Company Details
      • 15.3.2.2. Business Overview
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. Strategic Overview
      • 15.3.2.5. SWOT Analysis
    • 15.3.3. GlaxoSmithKline plc
      • 15.3.3.1. Company Details
      • 15.3.3.2. Business Overview
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. Strategic Overview
      • 15.3.3.5. SWOT Analysis
    • 15.3.4. Novartis AG
      • 15.3.4.1. Company Details
      • 15.3.4.2. Business Overview
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. Strategic Overview
      • 15.3.4.5. SWOT Analysis
    • 15.3.5. Melinta Therapeutics
      • 15.3.5.1. Company Details
      • 15.3.5.2. Business Overview
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. Strategic Overview
      • 15.3.5.5. SWOT Analysis
    • 15.3.6. Dr Reddy's Laboratories Ltd
      • 15.3.6.1. Company Details
      • 15.3.6.2. Business Overview
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. Strategic Overview
      • 15.3.6.5. SWOT Analysis
    • 15.3.7. Sanofi S.A.
      • 15.3.7.1. Company Details
      • 15.3.7.2. Business Overview
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. Strategic Overview
      • 15.3.7.5. SWOT Analysis

List of Tables

  • Table 01: Pipeline Analysis
  • Table 02: Global Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016-2026
  • Table 03: Global Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016-2026
  • Table 04: Global Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • Table 05: Global Bronchitis Treatment Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • Table 06: North America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Country, 2016-2026
  • Table 07: North America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016-2026
  • Table 08: North America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016-2026
  • Table 09: North America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • Table 10: Europe Bronchitis Treatment Market Value (US$ Mn) Forecast, by Country/Region 2016-2026
  • Table 11: Europe Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016-2026
  • Table 12: Europe Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016-2026
  • Table 13: Europe Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • Table 14: Asia Pacific Bronchitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region 2016-2026
  • Table 15: Asia Pacific Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016-2026
  • Table 16: Asia Pacific Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016-2026
  • Table 17: Asia Pacific Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • Table 18: Latin America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 19: Latin America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016-2026
  • Table 20: Latin America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016-2026
  • Table 21: Latin America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • Table 22: Middle East & Africa Bronchitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region,
  • Table 23: Middle East & Africa Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016-2026
  • Table 24: Middle East & Africa Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016-2026
  • Table 25: Middle East & Africa Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026

List of Figures

  • Figure 01: Global Bronchitis Treatment Market Value (US$ Mn) and Distribution, by Region, 2018 and 2026
  • Figure 02: Global Bronchitis Treatment Market Revenue Projection (US$ Mn), 2016-2026
  • Figure 03: Global Bronchitis Treatment Market Value Share, by Type, 2017
  • Figure 04: Global Bronchitis Treatment Market Value Share, by Drug Class, 2017
  • Figure 05: Global Bronchitis Treatment Market Value Share, by Region, 2017
  • Figure 06: Global Bronchitis Treatment Market Value Share, by Distribution Channel, 2017
  • Figure 07: Global Bronchitis Treatment Market Value Share Analysis by Type, 2017 and 2026
  • Figure 08: Global Bronchitis Treatment Market Attractiveness, by Type, 2018-2026
  • Figure 09: Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Chronic Bronchitis, 2016-2026
  • Figure 10: Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Acute Bronchitis, 2016-2026
  • Figure 11: Global Bronchitis Treatment Market Value Share Analysis by Drug Class, 2017 and 2026
  • Figure 12: Global Bronchitis Treatment Market Attractiveness, by Drug Class, 2018-2026
  • Figure 13: Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Antibiotics, 2016-2026
  • Figure 14: Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Anti-Inflammatory Drugs, 2016-2026
  • Figure 15: Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Bronchodilators, 2016-2026
  • Figure 16: Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Mucolytics, 2016-2026
  • Figure 17: Global Bronchitis Treatment Market Value Share, by Distribution Channel, 2017 and 2026
  • Figure 18: Global Bronchitis Treatment Market Attractiveness, by Distribution Channel, 2018-2026
  • Figure 19: Global Bronchitis Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2016-2026
  • Figure 20: Global Bronchitis Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2016-2026
  • Figure 21: Global Bronchitis Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2016-2026
  • Figure 22: Global Bronchitis Treatment Market Value Share, by Region, 2016 and 2025
  • Figure 23: Global Bronchitis Treatment Market Attractiveness, by Region, 2018-2026
  • Figure 24: North America Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018-2026
  • Figure 25: North America Bronchitis Treatment Market Value Share Analysis, by Country, 2017 and 2026
  • Figure 26: North America Bronchitis Treatment Market Attractiveness Analysis, by Country, 2018-2026
  • Figure 27: North America Bronchitis Treatment Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 28: North America Bronchitis Treatment Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 29: North America Bronchitis Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 30: North America Bronchitis Treatment Market Attractiveness Analysis, by Type, 2018-2026
  • Figure 31: North America Bronchitis Treatment Market Attractiveness Analysis, by Drug Class, 2018-2026
  • Figure 32: North America Bronchitis Treatment Market Attractiveness Analysis, by Distribution Channel, 2018-2026
  • Figure 33: Europe Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018-2026
  • Figure 34: Europe Bronchitis Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 35: Europe Bronchitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 36: Europe Bronchitis Treatment Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 37: Europe Bronchitis Treatment Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 38: Europe Bronchitis Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 39: Europe Bronchitis Treatment Market Attractiveness Analysis, by Type, 2018-2026
  • Figure 40: Europe Bronchitis Treatment Market Attractiveness Analysis, by Drug Class, 2018-2026
  • Figure 41: Europe Bronchitis Treatment Market Attractiveness Analysis, by Distribution Channel, 2018-2026
  • Figure 42: Asia Pacific Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016-2026
  • Figure 43: Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 44: Asia Pacific Bronchitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 45: Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 46: Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 47: Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 48: Asia Pacific Bronchitis Treatment Market Attractiveness Analysis, by Type, 2018-2026
  • Figure 49: Asia Pacific Bronchitis Treatment Market Attractiveness Analysis, by Drug Class, 2018-2026
  • Figure 50: Asia Pacific Bronchitis Treatment Market Attractiveness Analysis, by Distribution Channel, 2018-2026
  • Figure 51: Latin America Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016-2026
  • Figure 52: Latin America Bronchitis Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 53: Latin America Bronchitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 54: Latin America Bronchitis Treatment Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 55: Latin America Bronchitis Treatment Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 56: Latin America Bronchitis Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 57: Latin America Bronchitis Treatment Market Attractiveness Analysis, by Type, 2018-2026
  • Figure 58: Latin America Bronchitis Treatment Market Attractiveness Analysis, by Drug Class, 2018-2026
  • Figure 59: Latin America Bronchitis Treatment Market Attractiveness Analysis, by Distribution Channel, 2018-2026
  • Figure 60: Middle East & Africa Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016-2026
  • Figure 61: Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 62: Middle East & Africa Bronchitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 63: Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 64: Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 65: Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 66: Middle East & Africa Bronchitis Treatment Market Attractiveness Analysis, by Type, 2018-2026
  • Figure 67: Middle East & Africa Bronchitis Treatment Market Attractiveness Analysis, by Drug Class, 2018-2026
  • Figure 68: Middle East & Africa Bronchitis Treatment Market Attractiveness Analysis, by Distribution Channel, 2018-2026
  • Figure 69: Global Bronchitis Treatment Market Share, by Company, 2017
  • Figure 70: AstraZeneca Breakdown of Net Sales (%), by Region, 2017
  • Figure 71: AstraZeneca R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2017
  • Figure 72: AstraZeneca Breakdown of Net Sales (%), by Product Segment, 2017
  • Figure 73: Boehringer Ingelheim International GmbH, Human Pharmaceuticals Business Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2017
  • Figure 74: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Region, 2017
  • Figure 75: Boehringer Ingelheim International GmbH R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2017
  • Figure 76: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Business Segment, 2017
  • Figure 77: GlaxoSmithKline plc Respiratory Business Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2017
  • Figure 78: GlaxoSmithKline plc Breakdown of Net Sales (%), by Region, 2017
  • Figure 80: GlaxoSmithKline plc Breakdown of Net Sales (%), by Business Segment, 2017
  • Figure 81: Novartis AG COPD Portfolio Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2017
  • Figure 82: Novartis AG Breakdown of Net Sales (%), by Country, 2017
  • Figure 83: Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2017
  • Figure 84: Novartis AG Breakdown of Net Sales (%), by Business Segment, 2017
  • Figure 85: Melinta Therapeutics Respiratory Medicine Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2017
  • Figure 86: Melinta Therapeutics Breakdown of Net Sales (%), by Region, 2017
  • Figure 87: Melinta Therapeutics R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2017
  • Figure 88: Melinta Therapeutics Breakdown of Net Sales (%), by Business Segment, 2017
  • Figure 89: Dr Reddy's Laboratories Ltd., Ltd Pharmaceuticals Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2017
  • Figure 90: Dr Reddy's Laboratories Ltd., Breakdown of Net Sales (%), by Region, 2017
  • Figure 91: Dr Reddy's Laboratories Ltd., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2017
  • Figure 92: Dr Reddy's Laboratories Ltd., Breakdown of Net Sales (%), by Product Segment, 2017
  • Figure 93: Sanofi S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2017
  • Figure 94: Sanofi S.A. Breakdown of Net Sales (%), by Region, 2017
  • Figure 95: Sanofi S.A. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2017
  • Figure 96: Sanofi S.A. Breakdown of Net Sales (%), by Therapeutics Area, 2017